HCPLive

Plaque Psoriasis

Latest Headlines

Interleukin-17 (IL-17) Inhibitors in Plaque Psoriasis Treatment
Interleukin-17, one of the T-helper 1 (Th17) subtypes had been reported to be a significant trigger for plaque psoriasis however the specific contribution of each cytokine group still remains questionable.
Genetic Biomarker Associated with Psoriatic Arthritis, But Not Psoriasis
Although psoriatic arthritis (PsA) only targets those diagnosed with psoriasis, a genetic factor has been discovered that only pinpoints the former.
Diagnose this Patient's Rash
A 50-year-old forest ranger noted this rash, which he thinks has been present for several weeks. He noticed a similar rash on his dog. It is itchy, with a raised red border and a clear center. It may have increased in size slightly over several weeks. He is otherwise asymptomatic. What is the next step in treating him?
Promising Phase 3 Trial Results for Ixekizumab for the Treatment of Psoriatic Arthritis
Patients in the SPIRIT-P1 trial with active psoriatic arthritis treated with ixekizumab achieved significant improvement as measured by ACR20 compared to patients who received placebo.
Docs Want to Demote Dr. Oz
TV Host Mehmet Oz, MD has survived professionally despite criticism of his promotion of questionable weight loss remedies. In the latest assault, 10 physicians publicized a letter they wrote the Columbia University College of Physicians and Surgeons' dean, protesting Oz's faculty appointment in the department of surgery.
Guttate Psoriasis As a Prognostic Marker for Plaque Psoriasis
The first guttate psoriasis (GP) episode, which is often triggered by an acute infection such as streptococcal pharyngitis, often results in patients developing chronic plaque psoriasis, according to research presented at the 73rd American Academy of Dermatology Annual Meeting.

Most Popular

$vacMongoViewPlus$ $vAR$